臨床試驗

Multi-target TMS for Schizophrenia Negative Symptoms

NCT：NCT07559084 · NOT_YET_RECRUITING

NCT IDNCT07559084

狀態NOT_YET_RECRUITING

開始日期2026-10-01

完成時間2028-01-30

SponsorShanghai Mental Health Center (OTHER)

First posted2026-04-30

Last updated2026-09-10

簡要摘要

This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the right orbitofrontal cortex (R-OFC), left dorsolateral prefrontal cortex (L-DLPFC), and left inferior parietal lobule (L-IPL) for negative symptoms of schizophrenia.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。